1. Cancer immunotherapy: the beginning of the end of cancer?;S Farkona;BMC Med,2016
2. Immunotherapy resistance: the answers lie ahead—not in front—of us;MC Andrews;J Immunother Cancer,2017
3. EMA. Guideline on potency testing of cell based immunotherapy medicinal products for the treatment of cancer. European Medicines Agency; 2016, July 21.
4. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy;C de Wolf;Cytotherapy,2017
5. FDA. Guidance for Industry, Potency Tests for Cellular and Gene Therapy Products 2017 Jan 25. https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm072571.htm.